DIN 02524376 — HYQVIA 400 UNIT; 5 G
HYQVIA is a solution of Immunoglobulin (Human) / Hyaluronidase (Recombinant Human) marketed by TAKEDA CANADA INC. The full Immunoglobulin (Human) / Hyaluronidase (Recombinant Human) monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02524376
- Brand name
- HYQVIA
- Active ingredient
- Immunoglobulin (Human) / Hyaluronidase (Recombinant Human)
- Strength
- 400 UNIT; 5 G
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- TAKEDA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Immunoglobulin replacement therapy with recombinant human hyaluronidase (facilitates subcutaneous absorption)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Immunoglobulin (Human) / Hyaluronidase (Recombinant Human) products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02524368 | HYQVIA | 2.5 G; 200 UNIT | SOLUTION | TAKEDA CANADA INC | MARKETED |
| 02524392 | HYQVIA | 20 G; 1600 UNIT | SOLUTION | TAKEDA CANADA INC | MARKETED |
| 02524406 | HYQVIA | 2400 UNIT; 30 G | SOLUTION | TAKEDA CANADA INC | MARKETED |
| 02524384 | HYQVIA | 800 UNIT; 10 G | SOLUTION | TAKEDA CANADA INC | MARKETED |